MedTrace Logo

Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans

NCT01688154 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2013-07-03

No results posted yet for this study

Summary

Grape seed proanthocyanidins have been reported to possess a hypotriglyceridemic effect after an acute or chronic consumption in rodents. In this study, we aimed to investigate the effects of an acute consumption of proanthocyanidins before a breakfast meal in humans. Moreover, the mechanisms implicated in the reduction of plasma triglycerides levels by grape seed proanthocyanidins in humans should be elucidated as well as its activity on vascular function.

Conditions

  • Triglyceride Metabolism
  • Cardiovascular Function

Interventions

DIETARY_SUPPLEMENT

35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)

OTHER

2 empty capsules

Sponsors & Collaborators

  • University Rovira i Virgili

    collaborator OTHER

  • Hospital Universitari Sant Joan de Reus

    collaborator OTHER

  • Technological Centre of Nutrition and Health, Spain

    lead OTHER

Principal Investigators

  • Rosa Solà, PhD · University Rovira i Virgili

  • Maria Cinta Bladé, PhD · University Rovira i Virgili

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-05-31
Completion
2013-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01688154 on ClinicalTrials.gov